- Home
- CUTR vs ABVC Comparison
CUTR vs ABVC Comparison
Compare CUTR & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUTR
- ABVC
- Stock Information
- Founded
- CUTR 1988
- ABVC 2015
- Country
- CUTR United States
- ABVC United States
- Employees
- CUTR N/A
- ABVC N/A
- Industry
- CUTR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- CUTR Health Care
- ABVC Health Care
- Exchange
- CUTR Nasdaq
- ABVC Nasdaq
- Market Cap
- CUTR 7.3M
- ABVC 6.5M
- IPO Year
- CUTR 2004
- ABVC N/A
- Fundamental
- Price
- CUTR $0.32
- ABVC $0.55
- Analyst Decision
- CUTR Hold
- ABVC
- Analyst Count
- CUTR 3
- ABVC 0
- Target Price
- CUTR $3.00
- ABVC N/A
- AVG Volume (30 Days)
- CUTR 433.8K
- ABVC 165.5K
- Earning Date
- CUTR 11-07-2024
- ABVC 11-14-2024
- Dividend Yield
- CUTR N/A
- ABVC N/A
- EPS Growth
- CUTR N/A
- ABVC N/A
- EPS
- CUTR N/A
- ABVC N/A
- Revenue
- CUTR $155,210,000.00
- ABVC $509,788.00
- Revenue This Year
- CUTR N/A
- ABVC N/A
- Revenue Next Year
- CUTR $4.81
- ABVC N/A
- P/E Ratio
- CUTR N/A
- ABVC N/A
- Revenue Growth
- CUTR N/A
- ABVC N/A
- 52 Week Low
- CUTR $0.28
- ABVC $0.41
- 52 Week High
- CUTR $4.97
- ABVC $2.45
- Technical
- Relative Strength Index (RSI)
- CUTR 24.65
- ABVC 46.18
- Support Level
- CUTR $0.36
- ABVC $0.53
- Resistance Level
- CUTR $0.63
- ABVC $0.59
- Average True Range (ATR)
- CUTR 0.05
- ABVC 0.05
- MACD
- CUTR -0.01
- ABVC 0.00
- Stochastic Oscillator
- CUTR 10.46
- ABVC 38.16
About CUTR Cutera Inc.
Cutera Inc is a medical device company. It specializes in the design, development, manufacture, marketing and servicing of laser and other energy based aesthetics systems for practitioners internationally. Its products include enlighten, excel HR, excel V, Xeo and Trusculpt 3D among others. The company markets and sells its products under the trademarks such as Cutera, Acutip, Coolglide, Enlighten, Excel HR, Excel V, Genesis plus, Pico-genesis, Titan, Trusculpt, and Xeo among others. It derives the majority of its revenue from the United States geographic segment.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.